Sparks_2006_Acta.Neurol.Scand.Suppl_185_3

Reference

Title : Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial - Sparks_2006_Acta.Neurol.Scand.Suppl_185_3
Author(s) : Sparks DL , Connor DJ , Sabbagh MN , Petersen RB , Lopez J , Browne P
Ref : Acta Neurologica Scandinavica Supplementum , 185 :3 , 2006
Abstract : Sparks_2006_Acta.Neurol.Scand.Suppl_185_3
ESTHER : Sparks_2006_Acta.Neurol.Scand.Suppl_185_3
PubMedSearch : Sparks_2006_Acta.Neurol.Scand.Suppl_185_3
PubMedID: 16866904

Related information

Citations formats

Sparks DL, Connor DJ, Sabbagh MN, Petersen RB, Lopez J, Browne P (2006)
Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial
Acta Neurologica Scandinavica Supplementum 185 :3

Sparks DL, Connor DJ, Sabbagh MN, Petersen RB, Lopez J, Browne P (2006)
Acta Neurologica Scandinavica Supplementum 185 :3